Abstract:Background Acute Myocardial Infarction (AMI) represents a significant clinical challenge with diverse outcomes. Predicting patient-oriented composite endpoints (POCE) (all-cause death, any stroke, any AMI, or any revascularization) can significantly enhance post-AMI care. Incorporating clinical data with neuroendocrine biomarkers may offer improved prognostic capabilities. Objective To develop and validate a machine learning model to predict POCE in AMI patients, utilizing clinical parameters and neuroendocrine biomarkers. Methods There was prospective, observational, single-center study. Three approaches have been used to obtain the predictions for POCE event. First, as the dataset was imbalanced, an adaptive synthetic (ADASYN) sampling approach was used to generate synthetic instances, particularly focusing on those that are difficult-to-learn by using a weighted distribution. Then, random forest classifier (RF) was used to build a machine learning model to predict POCE. The model was tuned via a grid-search algorithm for optimal hyperparameters and validated using a 10-fold stratified cross-validation. Finally, the feature importance was determined by Shapley Additives, which measure the average marginal contribution of a feature value across all potential feature combinations. For the comparative purpose, the Gini index, which also shows the feature importance but in terms of mean decrease in impurity, was calculated. Results The study incorporated data from 315 patients, examining 47 variables and identifying 72 instances of POCE. After applying the ADASYN algorithm, the class distribution within the dataset was effectively equalized, facilitating the training of a robust RF model. Upon training with 252 instances, the model distinguished POCE with an accuracy of 83.8%, demonstrating a sensitivity of 80% and a specificity of 86%. During 10-fold cross-validation, the model's accuracy slightly dipped to 75%, with a sensitivity of 56% and specificity of 82%, indicating a balance between generalizability and overfitting. Testing mirrored these results, underscoring the model's consistent performance. Notably, SHAP value analysis highlighted C-Reactive Protein (CRP) and alanine transaminase (ALT) as the most influential features, underscoring their significance in the context of AMI (Figure 1-2). The predictive power of each feature was further demonstrated by the mean decrease in Gini index (Figure 1-2). Conclusion Our study highlights the feasibility of employing machine learning to predict POCE post-AMI using an integrative dataset of clinical and neuroendocrine markers. The predictive model has the potential to revolutionize post-AMI care by allowing clinicians to identify high-risk patients early, tailor interventions, and allocate resources efficiently. Future research could explore the integration of this model into clinical workflows and its impact on patient outcomes.

Combined Metabolomics and Machine Learning Algorithms to Explore Metabolic Biomarkers for Diagnosis of Acute Myocardial Ischemia.

Identification Of Potential Biomarkers And Immune Cell Infiltration In Acute Myocardial Infarction (Ami) Using Bioinformatics Strategy

A machine learning-based approach for the prediction of periprocedural myocardial infarction by using routine data

Cross-comparative Metabolomics Reveal Sex-Age Specific Metabolic Fingerprints and Metabolic Interactions in Acute Myocardial Infarction.

Combining the Strengths of the Explainable Boosting Machine and Metabolomics Approaches for Biomarker Discovery in Acute Myocardial Infarction

Forensic identification of sudden cardiac death: a new approach combining metabolomics and machine learning

Multinomial machine learning identifies independent biomarkers by integrated metabolic analysis of acute coronary syndrome

Plasma Metabolic Profiling and Multiclass Diagnostic Model Development for Stable Angina Pectoris and Acute Myocardial Infarction

Urine Metabolites Changes in Acute Myocardial Infarction Rats via Metabolomic Analysis

Identification of Featured Metabolism-Related Genes in Patients with Acute Myocardial Infarction

Prognostic Value of Machine Learning in Patients with Acute Myocardial Infarction

Metabolomics Analysis Identifies Differential Metabolites as Biomarkers for Acute Myocardial Infarction

Investigation of serum metabolic profiling in late-stage of acute myocardium infarction in rats

Towards real-time myocardial infarction diagnosis: a convergence of machine learning and ion-exchange membrane technologies leveraging miRNA signatures

Exploring biomarkers for identifying acute myocardial infarction based on lipidomics

Accurate Classification and Prediction of Acute Myocardial Infarction through an ARMD Procedure.

Three-Biomarker Joint Strategy for Early and Accurate Diagnosis of Acute Myocardial Infarction Via a Multiplex Electrochemiluminescence Immunoarray Coupled with Robust Machine Learning

Integrative machine learning model for predicting patient-oriented composite endpoints in acute myocardial infarction: a neuroendocrine biomarker approach

Dynamic molecular signatures of acute myocardial infarction based on transcriptomics and metabolomics

Identification of molecular signatures in acute myocardial infarction based on integrative analysis of proteomics and transcriptomics

Machine-Learning for Phenotyping and Prognostication of Myocardial Infarction and Injury in Suspected Acute Coronary Syndrome